Table 2.
Comparison between baseline and follow-up activity scores in all patients with inflammatory bowel diseases (IBD) and those with and without H. pylori infection
| Baseline | Follow-up | p | |
|---|---|---|---|
| Total IBD patients n = 76 | |||
| Ulcerative colitis n = 45 (59.2) | |||
| PUCAI 0—35 | 24 (53.3) | 40 (88.9) | 0.0004 |
| PUCAI > 35 | 21 (46.7) | 5 (11.1) | 0.0004 |
| UCEIS 0 – 4 | 20 (44.4) | 38 (84.4) | 0.0001 |
| UCEIS 5 – 8 | 25 (55.6) | 7 (15.6) | 0.0001 |
| Crohn disease n= 29 (38.2) | |||
| PCDAI 0—40 | 23 (79.3) | 29 (100.0) | 0.0235 |
| PCDAI > 40 | 6 (20.7) | 0 | 0.0235 |
| SES-CD 0—6 | 4 (13.8) | 18 (62.1) | 0.0003 |
| SES-CD > 7 | 25 (86.2) | 11 (37.9) | 0.0003 |
| IBD patients with H. pylori infection n = 7 | |||
| Ulcerative colitis n = 4 (57.1) | |||
| PUCAI 0 – 35 | 2 (50.0) | 4 (100.0) | 0.4286 |
| PUCAI > 35 | 2 (50.0) | 0 | 0.4286 |
| UCEIS 0—4 | 3 (75.0) | 4 (100.0) | 1.000 |
| UCEIS 5—8 | 1 (25.0) | 0 | 1.000 |
| Crohn disease n = 3 (42.9) | |||
| PCDAI 0—40 | 3 (100.0) | 3 (100.0) | 1.000 |
| PCDAI > 40 | 0 | 0 | 1.000 |
| SES-CD 0—6 | 0 | 3 (100.0) | 1.000 |
| SES-CD > 7 | 3 (100.0) | 0 | 1.000 |
| IBD patients without H. pylori infection n = 69 | |||
| Ulcerative colitis n = 41 (59.4) | |||
| PUCAI 0 – 35 | 22 (53.7) | 36 (87.8) | 0.0013 |
| PUCAI > 35 | 19 (46.3) | 5 (12.2) | 0.0013 |
| UCEIS 0—4 | 17 (41.5) | 34 (82.9) | 0.0002 |
| UCEIS 5—8 | 24 (58.5) | 7 (17.1) | 0.0002 |
| Crohn disease n = 26 (37.7) | |||
| PCDAI 0—40 | 20 (76.9) | 26 (100.0) | 0.0226 |
| PCDAI > 40 | 6 (23.1) | 0 | 0.0226 |
| SES-CD 0—6 | 4 (15.4) | 15 (57.7) | 0.0034 |
| SES-CD > 7 | 22 (84.6) | 11 (42.3) | 0.0034 |
Data were expressed as number (percentage) of the total
PUCAI Pediatric Ulcerative Colitis Activity Index
UCEIS Ulcerative Colitis Endoscopic Index of Severity
PCDAI Pediatric Crohn’s Disease Activity Index
SES-CD Simple Endoscopic Score for Crohn’s Disease